SB253
Senate · 2025 sessionBipartisanKilled in SenateProtect 340B drug program access
AIProhibits drug manufacturers from denying or restricting a covered entity's acquisition of a 340B program drug and from requiring certain claims or utilization data unless required by federal law, making violations subject to the consumer protection act.
relative to participation in the federal 340B Drug Pricing Program.
Welfare/Medicare/MedicaidBusiness and IndustryCivil Actions
Status
Killed in the Senate — Inexpedient to Legislate · March 6, 2025- ✓Introduced
- ✕Senate
- House
- Governor
- Law
Division of testimony
0 submissionsSupport 0Oppose 0Neutral 0
No testimony matches these filters. Clear the search or set position to All.